Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE)-- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman ...

JDK 26 moves to general production availability. This short-term release is backed by six months of Premier-level support. Java Development Kit (JDK) 26, the latest standard Java release from Oracle, ...

For a decade, the trope has been a reliable—and lazy—way to elevate pet peeves into trends. The bro is someone who conforms to a type to an irritating degree, but he is also similar to his critics in ...

The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...

A man in Johannesburg shared a Senior Java Developer’s payslip, showing a basic salary of a substantial amount The developer, who had seven years of experience, had a salary after deductions that ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

His exhibition at SFMOMA could have examined the collapse of culture at the hands of commodity, but instead it nudges us toward the gift shop. KAWS is the pseudonym of American artist Brian Donnelly.

Conor Wight joined WCCO after cultivating his skills as an award-winning investigative reporter in Syracuse, NY. As a newcomer to Minnesota, he's excited to explore this beautiful state and all that ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...